title: Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis.
abstract: Neuronal death, which follows ischemic injury or is triggered by excitotoxins, can occur by both apoptosis and necrosis. Caspases, which are not directly required for necrotic cell death, are central mediators of the apoptotic program. Here we demonstrate that caspases cleave and inactivate the plasma membrane Ca(2+) pump (PMCA) in neurons and non-neuronal cells undergoing apoptosis. PMCA cleavage impairs intracellular Ca(2+) handling, which results in Ca(2+) overload. Expression of non-cleavable PMCA mutants prevents the disturbance in Ca(2+) handling, slows down the kinetics of apoptosis, and markedly delays secondary cell lysis (necrosis). These findings suggest that caspase-mediated cleavage and inactivation of PMCAs can lead to necrosis, an event that is reduced by caspase inhibitors in brain ischemia.
authors.affiliation: Molecular Toxicology, Faculty of Biology, University of Konstanz, Germany.
authors.forename: B L
authors.initials: BL
authors.lastname: Schwab
authors.forename: D
authors.initials: D
authors.lastname: Guerini
authors.forename: C
authors.initials: C
authors.lastname: Didszun
authors.forename: D
authors.initials: D
authors.lastname: Bano
authors.forename: E
authors.initials: E
authors.lastname: Ferrando-May
authors.forename: E
authors.initials: E
authors.lastname: Fava
authors.forename: J
authors.initials: J
authors.lastname: Tam
authors.forename: D
authors.initials: D
authors.lastname: Xu
authors.forename: S
authors.initials: S
authors.lastname: Xanthoudakis
authors.forename: D W
authors.initials: DW
authors.lastname: Nicholson
authors.forename: E
authors.initials: E
authors.lastname: Carafoli
authors.forename: P
authors.initials: P
authors.lastname: Nicotera
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001665:Binding Sites / Q000187:drug effects / Q000502:physiology; D016466:CHO Cells; D002118:Calcium / Q000378:metabolism; D020013:Calcium Signaling / Q000187:drug effects / Q000502:physiology; D000252:Calcium-Transporting ATPases / Q000187:drug effects / Q000378:metabolism*; D053148:Caspase 3; D020169:Caspases / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D027682:Cation Transport Proteins; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology*; D002999:Clone Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D004396:Coloring Agents; D006224:Cricetinae; D020925:Hypoxia-Ischemia, Brain / Q000201:enzymology* / Q000473:pathology / Q000503:physiopathology; D007150:Immunohistochemistry; D007424:Intracellular Fluid / Q000378:metabolism; D051379:Mice; D009154:Mutation / Q000187:drug effects / Q000235:genetics; D009336:Necrosis; D009474:Neurons / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D009498:Neurotoxins / Q000494:pharmacology; D053499:Plasma Membrane Calcium-Transporting ATPases; D051381:Rats
chemical_list: D027682:Cation Transport Proteins; D004396:Coloring Agents; D009498:Neurotoxins; C505409:Casp3 protein, mouse; C505410:Casp3 protein, rat; D053148:Caspase 3; D020169:Caspases; D053499:Plasma Membrane Calcium-Transporting ATPases; D000252:Calcium-Transporting ATPases; D002118:Calcium